CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus Angiotensin–neprilysin inhibition versus enalapril in heart failure Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure

Guideline2018 Oct 31.

JOURNAL:Heart Rhythm. Article Link

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Kusumoto FM, Schoenfeld MH, Barrett C et al. Keywords: bradycardia; cardiac conduction delay; guideline; ACC; AHA

FULL TEXT PDF